- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 78.67M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 71.61M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$92.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$54.82M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $159.73M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $261.75M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.17B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.25B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.01B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.07B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $81.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $91.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $156.78M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $164.37M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.31B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.39B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.33B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.41B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.39 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.39 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $35.8M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $20.39M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $83.61M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $74.42M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$109.28M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$425.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$84.58M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$119.41M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$94.81M |